Coronavirus outbreak: Drug pricing regulator asks companies to give information on price, inventory

The government has been examining the impact of the shutdown in China on the pharmaceutical sector in India. The DoP has also asked the country’s drug regulatory authority, Central Drugs Standard Control Organization, to examine to what degree India depends on China for bulk drugs, possible shortages of molecules and measures that can be taken to keep the situation under control.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2TqWJeK
via IFTTT